Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2012 (2012), Article ID 856085, 9 pages
http://dx.doi.org/10.1155/2012/856085
Research Article

Combination Therapy with Losartan and Pioglitazone Additively Reduces Renal Oxidative and Nitrative Stress Induced by Chronic High Fat, Sucrose, and Sodium Intake

1Department of Pharmacology, Third-Grade Pharmacology Laboratory of State Administration of Traditional Chinese Medicine, Wannan Medical College, Anhui, Wuhu 241002, China
2Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China
3Department of Gastroenterology, Yijishan Hospital Affiliated to Wannan Medical College, Anhui, Wuhu 241001, China
4Department of Nephrology, Yijishan Hospital Affiliated to Wannan Medical College, Anhui, Wuhu 241001, China

Received 15 August 2012; Revised 17 October 2012; Accepted 23 October 2012

Academic Editor: Guillermo Zalba

Copyright © 2012 Xiang Kong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. K. Roberts, R. J. Barnard, R. K. Sindhu, M. Jurczak, A. Ehdaie, and N. D. Vaziri, “A high-fat, refined-carbohydrate diet induces endothelial dysfunction and oxidant/antioxidant imbalance and depresses NOS protein expression,” Journal of Applied Physiology, vol. 98, no. 1, pp. 203–210, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. K. A. Amin, H. H. Kamel, and M. A. Abd Eltawab, “Protective effect of garcinia against renal oxidative stress and biomarkers induced by high fat and sucrose diet,” Lipids in Health and Disease, vol. 10, article 6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Andrews, P. A. Karadaghi, S. Memon et al., “No effect of high sucrose diets on the kidneys of wister kyoto (WKY) rats,” Geriatric Nephrology and Urology, vol. 2, no. 1, pp. 35–42, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Cianciaruso, V. Bellizzi, R. Minutolo et al., “Salt intake and renal outcome in patients with progressive renal disease,” Mineral and Electrolyte Metabolism, vol. 24, no. 4, pp. 296–301, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. J. W. Gu, A. P. Bailey, W. Tan, M. Shparago, and E. Young, “Long-term high-salt diet causes hypertension and decreases renal expression of vascular endothelial growth factor in sprague-dawley rats,” Journal of the American Society of Hypertension, vol. 2, no. 4, pp. 275–285, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. C. Fiore, P. M. Jimenez, D. Cremonezzi, L. I. Juncos, and N. H. García, “Statins reverse renal inflammation and endothelial dysfunction induced by chronic high salt intake,” The American Journal of Physiology, vol. 301, no. 2, pp. F263–F270, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Kong, D. Y. Zhang, H. B. Wu, and F. X. Li, “Losartan and pioglitazone ameliorate nephropathy in experimental metabolic syndrome rats,” Biological and Pharmaceutical Bulletin, vol. 34, no. 5, pp. 693–699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. H. M. Jin and Y. Pan, “Renoprotection provided by losartan in combination with pioglitazone is superior to renoprotection provided by losartan alone in patients with type 2 diabetic nephropathy,” Kidney and Blood Pressure Research, vol. 30, no. 4, pp. 203–211, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Namikoshi, N. Tomita, M. Satoh et al., “Pioglitazone enhances the antihypertensive and renoprotective effects of candesartan in zucker obese rats fed a high-protein diet,” Hypertension Research, vol. 31, no. 4, pp. 745–755, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. N. Lai, L. Y. Y. Chan, H. Guo, S. C. W. Tang, and J. C. K. Leung, “Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy,” Pediatric Nephrology, vol. 26, no. 2, pp. 257–266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Kong, J. R. Yang, L. Q. Guo et al., “Sesamin improves endothelial dysfunction in renovascular hypertensive rats fed with a high-fat, high-sucrose diet,” European Journal of Pharmacology, vol. 620, no. 1–3, pp. 84–89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Salvemini, T. M. Doyle, and S. Cuzzocrea, “Superoxide, peroxynitrite and oxidative/nitrative stress in inflammation,” Biochemical Society Transactions, vol. 34, no. 5, pp. 965–970, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. C. G. Schnackenberg, “Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature,” The American Journal of Physiology, vol. 282, no. 2, pp. R335–R342, 2002. View at Google Scholar · View at Scopus
  14. C. K. Roberts, N. D. Vaziri, R. K. Sindhu, and R. J. Barnard, “A high-fat, refined-carbohydrate diet affects renal NO synthase protein expression and salt sensitivity,” Journal of Applied Physiology, vol. 94, no. 3, pp. 941–946, 2003. View at Google Scholar · View at Scopus
  15. C. Kitiyakara, T. Chabrashvili, Y. Chen et al., “Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase,” Journal of the American Society of Nephrology, vol. 14, no. 11, pp. 2775–2782, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Satoh, S. Fujimoto, S. Arakawa et al., “Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy,” Nephrology Dialysis Transplantation, vol. 23, no. 12, pp. 3806–3813, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. E. M. de Cavanagh, L. F. Ferder, M. D. Ferder, I. Y. Stella, J. E. Toblli, and F. Inserra, “Vascular structure and oxidative stress in salt-loaded spontaneously hypertensive rats: effects of losartan and atenolol,” The American Journal of Hypertension, vol. 23, no. 12, pp. 1318–1325, 2010. View at Google Scholar · View at Scopus
  18. J. E. Toblli, M. G. Ferrini, G. Cao, D. Vernet, M. Angerosa, and N. F. Gonzalez-Cadavid, “Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus,” Nephrology Dialysis Transplantation, vol. 24, no. 8, pp. 2384–2391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. H. C. Yang, S. Deleuze, Y. Zuo, S. A. Potthoff, L. J. Ma, and A. B. Fogo, “The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury,” Journal of the American Society of Nephrology, vol. 20, no. 11, pp. 2380–2388, 2009. View at Google Scholar
  20. J. Qin, Z. Zhang, J. Liu et al., “Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes,” Kidney International, vol. 64, no. 2, pp. 565–571, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Kööbi, J. Kalliovalkama, P. Jolma et al., “AT1 receptor blockade improves vasorelaxation in experimental renal failure,” Hypertension, vol. 41, no. 6, pp. 1364–1371, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Benigni, C. Zoja, S. Tomasoni et al., “Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-γ agonist: molecular mechanism of the antiproteinuric effect of pioglitazone,” Journal of the American Society of Nephrology, vol. 17, no. 6, pp. 1624–1632, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. He, S. Yu, G. Mei et al., “Maternally transmitted milk containing recombinant human catalase provides protection against oxidation for mouse offspring during lactation,” Free Radical Biology and Medicine, vol. 45, no. 8, pp. 1135–1142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Fang, Y. Li, S. Du et al., “Variant rs9939609 in the FTO gene is associated with body mass index among Chinese children,” BMC Medical Genetics, vol. 11, no. 1, article 136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. N. D. Vaziri, “Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension,” Current Opinion in Nephrology and Hypertension, vol. 13, no. 1, pp. 93–99, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Chabrashvili, A. Tojo, M. L. Onozato et al., “Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney,” Hypertension, vol. 39, no. 2, pp. 269–274, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Taniyama and K. K. Griendling, “Reactive oxygen species in the vasculature: molecular and cellular mechanisms,” Hypertension, vol. 42, no. 6, pp. 1075–1081, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Halliwell, “What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo,” FEBS Letters, vol. 411, no. 2-3, pp. 157–160, 1997. View at Publisher · View at Google Scholar · View at Scopus